V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20208719 | 20077881 | 1.67 | 63 | Palliative (P) | 2019-10-10 | 2019-10-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100758668 |
| 20208727 | 20077882 | 1.77 | 55.7 | null | 2016-12-22 | 2017-01-07 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100835458 |
| 20208729 | 20077883 | 1.87 | 74 | Adjuvant (A) | 2019-08-12 | 2019-08-18 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100671967 |
| 20208731 | 20077884 | 1.63 | 14.5 | Palliative (P) | null | 2019-01-05 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100554403 |
| 20208733 | 20077885 | 1.7 | 78.6 | Palliative (P) | 2018-09-23 | 2018-09-24 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100427974 |
| 20208734 | 20077886 | 1.54 | null | Palliative (P) | 2018-09-30 | 2018-10-03 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100594907 |
| 20208738 | 20077887 | null | 85.1 | Palliative (P) | 2020-07-18 | 2020-07-20 | CAPECITABINE + CARBOPLATIN | N | null | DOXORUBICIN EMBOLISATION | 100627222 |
| 20208740 | 20077888 | null | 88 | Neo-adjuvant (N) | null | 2016-09-10 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100032381 |
| 20208746 | 20077889 | 1.71 | 92.5 | Palliative (P) | 2019-10-21 | 2019-10-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100261567 |
| 20208749 | 20077890 | 1.63 | 84.6 | Curative (C) | null | 2017-10-15 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 101495759 |
| 20208751 | 20077891 | 1.73 | 83.2 | Adjuvant (A) | 2016-08-13 | 2016-08-15 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101248459 |
| 20208755 | 20077892 | null | null | Neo-adjuvant (N) | 2017-06-03 | 2017-06-12 | CAPECITABINE + CARBOPLATIN | N | Y | DOXORUBICIN EMBOLISATION | 100137462 |
| 20208756 | 20077893 | 1.82 | 87 | Neo-adjuvant (N) | 2018-08-22 | 2018-09-04 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 101650691 |
| 20208757 | 20077894 | 1.67 | 75.2 | Neo-adjuvant (N) | 2019-12-20 | 2020-01-01 | CISPLATIN + FLUOROURACIL | N | Y | CISPLATIN + FLUOROURACIL | 100596504 |
| 20208758 | 20077895 | 1.7 | 62.7 | Palliative (P) | 2016-04-09 | 2016-04-09 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100476395 |
| 20208761 | 20077896 | null | 82.2 | Palliative (P) | 2019-03-05 | 2019-03-15 | Cisplatin + Fluorouracil + RT 5day | 02 | null | CISPLATIN + FLUOROURACIL | 101235985 |
| 20208765 | 20077897 | 0 | 0 | Curative (C) | 2018-12-19 | 2018-12-19 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101501006 |
| 20208766 | 20077898 | 1.54 | null | Palliative (P) | 2016-05-01 | 2016-05-18 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100576882 |
| 20208767 | 20077899 | 1.72 | 112.6 | 03 | 2016-11-18 | 2016-12-02 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100397400 |
| 20208768 | 20077900 | 1.82 | 90.5 | null | 2019-04-29 | 2019-04-29 | CAPECITABINE + CARBOPLATIN | N | N | CISPLATIN + FLUOROURACIL | 101831446 |
| 20208778 | 20077901 | 1.82 | 73.5 | Curative (C) | 2019-12-01 | 2019-12-01 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101302544 |
| 20208780 | 20077902 | 1.55 | 75 | Palliative (P) | 2017-12-21 | 2017-12-21 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100626341 |
| 20208784 | 20077903 | 1.71 | 74.9 | null | 2017-04-07 | 2017-04-30 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100323656 |
| 20208787 | 20077904 | 1.76 | 47 | null | 2019-02-25 | 2019-04-02 | CAPECITABINE + CARBOPLATIN | N | null | CAPECITABINE + CARBOPLATIN | 101252253 |
| 20208790 | 20077905 | 0 | 0 | Neo-adjuvant (N) | 2017-09-26 | 2017-10-13 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100813745 |
| 20208795 | 20077906 | 0 | 0 | null | 2016-12-26 | 2017-01-23 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101308843 |
| 20208805 | 20077907 | 1.53 | 67.6 | Palliative (P) | 2018-08-27 | 2018-09-04 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101226271 |
| 20208812 | 20077908 | 1.6 | 68.2 | Neo-adjuvant (N) | 2019-11-26 | 2019-12-04 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101748867 |
| 20208822 | 20077909 | 1.67 | 53.1 | Palliative (P) | 2018-09-25 | 2018-09-28 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100706877 |
| 20208826 | 20077910 | 0 | 0 | Palliative (P) | 2016-12-06 | 2016-12-13 | Doxorubicin chemoembolisation | null | null | DOXORUBICIN EMBOLISATION | 100072727 |
| 20208828 | 20077911 | 1.73 | 54 | null | 2016-08-20 | 2016-09-01 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100865315 |
| 20208831 | 20077912 | null | 46 | Neo-adjuvant (N) | null | 2019-07-27 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101698673 |
| 20208837 | 20077913 | 1.62 | 67 | null | 2018-02-26 | 2018-02-26 | Capecitabine + Carboplatin + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101679011 |
| 20208839 | 20077914 | 0 | 0 | Palliative (P) | 2019-10-12 | 2019-10-16 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100010126 |
| 20208840 | 20077915 | 1.7 | 65.2 | null | 2017-03-17 | 2017-03-18 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 100986161 |
| 20208841 | 20077916 | 1.67 | 90.4 | Curative (C) | 2019-07-15 | 2019-07-20 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 100557397 |
| 20208842 | 20077917 | 0 | 0 | Curative (C) | 2015-08-23 | 2016-05-29 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101298379 |
| 20208844 | 20077918 | 1.57 | 84.3 | Curative (C) | 2016-09-11 | 2016-09-17 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 100147697 |
| 20208847 | 20077919 | 1.68 | 67.5 | Palliative (P) | 2019-01-03 | 2019-01-19 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101085466 |
| 20208848 | 20077920 | 1.77 | 73 | Neo-adjuvant (N) | 2018-06-13 | 2018-06-25 | Capecitabine (21days) + Carboplatin | 02 | Y | CISPLATIN + FLUOROURACIL | 100831639 |
| 20208849 | 20077921 | null | null | null | 2019-07-28 | 2019-08-24 | CAPECITABINE + CARBOPLATIN | N | null | DOXORUBICIN EMBOLISATION | 100834770 |
| 20208850 | 20077922 | 1.66 | 66 | Palliative (P) | 2019-01-06 | 2019-01-15 | CISPLATIN + FLUOROURACIL | 2 | N | CISPLATIN + FLUOROURACIL | 100190776 |
| 20208856 | 20077923 | 1.53 | 62.8 | Curative (C) | 2019-10-30 | 2019-11-07 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101094144 |
| 20208858 | 20077924 | 0 | 0 | null | null | null | Doxorubicin chemoembolisation | null | null | DOXORUBICIN EMBOLISATION | 100648887 |
| 20208867 | 20077925 | 1.75 | 75.4 | Palliative (P) | 2016-10-15 | 2016-11-15 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100053280 |
| 20208875 | 20077926 | 1.71 | 49.4 | Neo-adjuvant (N) | 2018-10-16 | 2018-10-27 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 101044507 |
| 20208882 | 20077927 | null | 77.2 | Neo-adjuvant (N) | 2017-03-06 | 2017-03-26 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100035412 |
| 20208887 | 20077928 | 1.55 | 65.45 | Palliative (P) | 2019-11-06 | 2019-11-17 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 101484727 |
| 20208891 | 20077929 | 1.63 | 115.5 | Palliative (P) | 2018-03-02 | 2018-03-02 | Cisplatin + Fluorouracil + RT 5day | N | null | CISPLATIN + FLUOROURACIL | 100614783 |
| 20208906 | 20077930 | 1.71 | 52.05 | Neo-adjuvant (N) | 2018-07-04 | 2018-07-04 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 100217722 |